72 related articles for article (PubMed ID: 7648851)
1. Bladder stones formation eight months after treatment of hairy-cell leukemia with 2-chloro-deoxyadenosine: a case report.
Bessa O
Conn Med; 1995 Jun; 59(6):331. PubMed ID: 7648851
[No Abstract] [Full Text] [Related]
2. Treatment of patients with hairy cell leukemia with 2-chloro-2'-deoxyadenosine (2-CdA).
Robak T; Krykowski E; Błasińska-Morawiec M; Urbańska-Ryś H
Arch Immunol Ther Exp (Warsz); 1994; 42(1):25-9. PubMed ID: 7503629
[TBL] [Abstract][Full Text] [Related]
3. Treatment of hairy cell leukemia patients with 2-chloro-2'-deoxyadenosine (2-CdA).
Komarnicki M; Kaźmierczak M; Hansz J
Arch Immunol Ther Exp (Warsz); 1994; 42(1):31-2. PubMed ID: 7503630
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of patients with hairy cell leukemia (HCL) using a single cycle of 2-chloro-2'-deoxyadenosine (CdA).
Jehn U; Gawaz M; Grunewald R; Hill W; Lorenz B; Stôtzer O
Anticancer Res; 1993; 13(5C):1809-14. PubMed ID: 7903521
[TBL] [Abstract][Full Text] [Related]
5. [Progress in the treatment of hairy cell leukemia. Subcutaneous administration of 2-chloro-deoxy-adenosine for 7 days].
Heldal D; Tjønnfjord GE; Evensen SA; Juliusson G
Tidsskr Nor Laegeforen; 1994 Mar; 114(7):800-3. PubMed ID: 7912011
[TBL] [Abstract][Full Text] [Related]
6. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine).
Füreder W; Weltermann A; Chott A; Gisslinger H; Valent P; Jäger U; Geissler K; Lechner K
Wien Klin Wochenschr; 1999 Dec; 111(24):1027-30. PubMed ID: 10677889
[TBL] [Abstract][Full Text] [Related]
7. [Subcutaneous therapy of hairy cell leukemia with 2-chlorodeoxyadenosine].
Nielsen OJ; Hippe E; Priø TK; Juliusson G
Ugeskr Laeger; 1994 Apr; 156(16):2407-9. PubMed ID: 7912015
[TBL] [Abstract][Full Text] [Related]
8. Five day intermittent vs seven day continuous 2-chlorodeoxyadenosine infusion for the treatment of hairy cell leukemia. A study by Italian Group for the Hairy Cell Leukemia.
Damasio EE; Resegotti L; Masoudi B; Bruni R; Cerri R; Isaza A; Clavio M; Risso M; Rossi E; Spriano M; Truini M
Recenti Prog Med; 1998 Feb; 89(2):68-73. PubMed ID: 9558908
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of hairy cell leukemia patients treated with 2-chlorodeoxyadenosine.
Zinzani PL; Magagnoli M; Bendandi M; Tani M; Stefoni V; Cellini C; Poggi S; Piccioli M; Pileri S; Tura S
Haematologica; 2000 Sep; 85(9):922-5. PubMed ID: 10980629
[TBL] [Abstract][Full Text] [Related]
10. Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduces infectious complications.
Lauria F; Bocchia M; Marotta G; Raspadori D; Zinzani PL; Rondelli D
Haematologica; 1999 Jan; 84(1):22-5. PubMed ID: 10091389
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of hairy cell leukemia with cladribine].
Aurer I; Mitrović Z; Kovacević-Metelko J; Radman I; Basić-Kinda S; Gjadrov-Kuvezdić K; Jakić-Razumović J; Dubravcić K; Ries S; Nola M; Zupancic-Salek S; Labar B
Lijec Vjesn; 2007; 129(3-4):80-3. PubMed ID: 17557550
[TBL] [Abstract][Full Text] [Related]
12. Immediate or delayed therapy with 2-CdA for hairy cell leukemia in Jehova's Witness?
Juliusson G
Am J Hematol; 1996 Sep; 53(1):49. PubMed ID: 8813099
[No Abstract] [Full Text] [Related]
13. [Hypersensitivity reactions to multiple drugs during the course of hairy cell leukemia treated with 2-chlorodeoxyadenosine].
Kokunai A; Azusawa H; Murota H; Ohhata C; Katayama I; Murata S; Tadokoro S
Arerugi; 2006 Jun; 55(6):662-6. PubMed ID: 16883103
[TBL] [Abstract][Full Text] [Related]
14. Cladribine (2-chlorodeoxyadenosine) therapy in hairy cell leukemia variant. A report of three cases.
Palomera L; Domingo JM; Sola C; Azaceta G; Calvo MT; Gutierrez M
Haematologica; 2002 Jan; 87(1):107-8. PubMed ID: 11801472
[No Abstract] [Full Text] [Related]
15. Histological examination of the lacrimal gland after experimental administration of Cladribine.
Kwietniewska M; Czerny K
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):526-30. PubMed ID: 12898890
[TBL] [Abstract][Full Text] [Related]
16. Criteria for use of cladribine in adults.
Fedak MN
Am J Hosp Pharm; 1994 Sep; 51(17):2185-6. PubMed ID: 7985700
[No Abstract] [Full Text] [Related]
17. [Successful use of cladribine in the treatment of an elderly woman with typical hairy cell leukemia].
Terasaki Y; Okumura H; Hirose A; Ishiura Y; Yokawa S; Saito K; Nakao S
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1885-8. PubMed ID: 18030031
[TBL] [Abstract][Full Text] [Related]
18. [Successful induction and complete improvement of myelofibrosis and erythema nosodum with cladribine in a case of hairy cell leukemia].
Araki H; Matsunaga T; Murase K; Kuroda H; Kuribayashi K; Terui T; Niitsu Y
Gan To Kagaku Ryoho; 2004 Jun; 31(6):965-9. PubMed ID: 15222122
[TBL] [Abstract][Full Text] [Related]
19. Development of hairy cell leukemia in a patient with antiphospholipid syndrome.
Diz-Kucukkaya R; Dincol G; Kamali S; Kural F; Inanc M
Lupus; 2007; 16(4):286-8. PubMed ID: 17439936
[TBL] [Abstract][Full Text] [Related]
20. Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia: a new treatment schedule effective and safer in preventing infectious complications.
Lauria F; Bocchia M; Marotta G; Raspadori D; Zinzani PL; Rondelli D
Blood; 1997 Mar; 89(5):1838-9. PubMed ID: 9057674
[No Abstract] [Full Text] [Related]
[Next] [New Search]